01 July 1997
Acute renal failure in children and its long-term follow-up treatment
Maria MilerMed Sci Monit 1997; 3(4): HY563-572 :: ID: 501446
Abstract
Acute renal failure (ARF) is a state that endangers the life of patients. The patient outcome is dependant upon on many factors such as: patient age, the cause of renal failure, the degree of demage to the parenchyma, the methods and the speed of treatment, and many factors not always known.Tests on finding a relationship between certain factors and the prognosis have not proved successful. Not much is known about the long-term follow-up of ARF in children who have survived the acute phase of the disease. The analysis incorporated 118 children. Their ages ranged from 3 days postpartum to 5 years. All subjects were diagnosed with acute renal failure. The analysis was conducted on children by taking an initial patient history and then by follow-up out-patient control.It was determined that ARF had the highest percentage of occurrence in infants, with males having a higher rate of occurrence. The most commonly observed cause of ARF was hypovolemia, associated mostly with either diarrhea or with hemolytic-uremic syndrom (HUS). It was determined that a failure in the urinary system beyond the kidneys (post-renal) occurred only during the first year of life. Beyond that time, the nephrotic syndrom was most commonlyu observed with ARF. There was no concrete evidence for any relationship between a patient's age, the cause of ARF, and the developement of the acute phase of the illness. Severe cases of ARF (according to Giananton's criterium) dominated in the 2 year old age group and were not observed in patients above 3 years of age. It was determined that this form of ARF occured only in patients with HUS. It was shown that treatment by dialysis was most often associated with the advanced acute phase. In this study 33.9% of the sample group were treated with dialysis.
Keywords: acute renal failure, children, long-term follow-up treatment
Editorial
01 March 2024 : Editorial
Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-ThalassemiaDOI: 10.12659/MSM.944204
Med Sci Monit 2024; 30:e944204
In Press
18 Mar 2024 : Clinical Research
Sexual Dysfunction in Women After Tibial Fracture: A Retrospective Comparative StudyMed Sci Monit In Press; DOI: 10.12659/MSM.944136
21 Feb 2024 : Clinical Research
Potential Value of HSP90α in Prognosis of Triple-Negative Breast CancerMed Sci Monit In Press; DOI: 10.12659/MSM.943049
22 Feb 2024 : Review article
Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future ...Med Sci Monit In Press; DOI: 10.12659/MSM.943168
23 Feb 2024 : Clinical Research
A Study of 60 Patients with Low Back Pain to Compare Outcomes Following Magnetotherapy, Ultrasound, Laser, ...Med Sci Monit In Press; DOI: 10.12659/MSM.943732
Most Viewed Current Articles
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952